Here are three things to know:
1. Spinal Elements received FDA clearance in November for its Ti-Bond surface coating technology. The company’s portfolio includes a number of products featuring Ti-Bond, such as the Lucent XP height- and lordosis-expandable interbody device.
2. The company’s Clutch interspinous process device features a proprietary spring-activated mechanism designed to maintain active compression against the spinous processes to resist loosening and migration.
3. Jason Blain is a founder, president and CEO of Spinal Elements. Mr. Blain has nearly 20 years of experience in orthopedics.
More articles on devices:
ZygoFix begins human clinical trial of spinal facet joint fixation system: 4 things to know
What Morgan Stanley thinks of Smith & Nephew’s new CEO: 5 things to know
Moody’s report shows positive outlook for US medical device sector in 2019 — 5 insights
